Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Asia-Pacific Journal of Public Health|July 17, 2019
Prevalence and Persistence of Maternal Dengue Neutralizing Antibodies in Infants From Central and Southern Thailand: A Retrospective Cohort StudyAdrienne Guignard, François Haguinet, Stéphanie Wéry, et al.
Pharmaceutical Statistics|April 16, 2024
Tree-temporal scan statistics for safety signal detection in vaccine clinical trialsFrançois Haguinet, Fabian Tibaldi, Christophe Dessart, et al.
Drug Safety|January 11, 2022
Review of Over 15 Years Postmarketing Safety Surveillance Spontaneous Data for the Human Rotavirus Vaccine (Rotarix) on IntussusceptionTina Singh, Frédérique Delannois, François Haguinet, et al.
BMJ Open|February 8, 2013
Safety of AS03-adjuvanted split-virion H1N1 (2009) pandemic influenza vaccine: a prospective cohort studyIrwin Nazareth, Fernanda Tavares, Dominique Rosillon, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|February 23, 2026
Ontology-based Semantic Similarity Measures for Clustering Medical Concepts in Drug SafetyJeffery L Painter, François Haguinet, Gregory E Powell, et al.
Drug Safety|June 10, 2023
Developing an Artificial Intelligence-Guided Signal Detection in the Food and Drug Administration Adverse Event Reporting System (FAERS): A Proof-of-Concept Study Using Galcanezumab and Simulated DataFahed Al-Azzawi, Israa Mahmoud, François Haguinet, et al.
Pharmacoepidemiology and Drug Safety|November 14, 2025
Performance of the Self-Controlled Case Series With Active Comparators for Drug Safety Signal Detection Using the French Administrative Healthcare Database (SNDS)Astrid Coste, Angel Y S Wong, François Haguinet, et al.
Influenza and Other Respiratory Viruses|July 1, 2014
Estimates of mortality attributable to influenza and RSV in the United States during 1997-2009 by influenza type or subtype, age, cause of death, and risk statusGonçalo Matias, Robert Taylor, François Haguinet, et al.
BMC Public Health|March 22, 2017
Estimates of hospitalization attributable to influenza and RSV in the US during 1997-2009, by age and risk statusGonçalo Matias, Robert Taylor, François Haguinet, et al.
Drug Safety|December 7, 2023
Optimizing Signal Management in a Vaccine Adverse Event Reporting System: A Proof-of-Concept with COVID-19 Vaccines Using Signs, Symptoms, and Natural Language ProcessingGuojun Dong, Andrew Bate, François Haguinet, et al.
Pageof 3